Niranjana S. Mahantshetti

KLES Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi 590 010, 
Belgaum, KA, IN 
KLES Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi 590 010, 
Belgaum, KA, IN 

Overview

Niranjana Mahantshetti practices practicing medicine in Belgaum, India.

Her clinical expertise encompasses Asphyxia Neonatorum, Strep Throat, and Rubella.

She is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

KLES Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi 590 010, Belgaum, KA, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Open-label, Non-comparative Phase IV Clinical Study to Evaluate the Safety and Clinical Efficacy of Augmentin Extra Strength (ES)-600 in Children With Acute Otitis Media (AOM) in India
A Multicenter, Open-label, Non-comparative Phase IV Clinical Study to Evaluate the Safety and Clinical Efficacy of Augmentin Extra Strength (ES)-600 in Children With Acute Otitis Media (AOM) in India
Enrollment Status: Completed
Publish Date: June 10, 2024
Intervention Type: Drug
Study Drug: Augmentin (ES)-600
Study Phase: Phase 4

13 Total Publications

Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14®) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial.
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14®) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial.
Journal: Vaccines
Published: April 01, 2026

Frequently Asked Questions about Niranjana S. Mahantshetti

Is Niranjana S. Mahantshetti a top-rated expert for Asphyxia Neonatorum?

MediFind is an objective health platform that identifies experts based on real-world data. Niranjana S. Mahantshetti is classified as an Experienced expert for Asphyxia Neonatorum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Niranjana S. Mahantshetti participate in research or clinical trials?

Yes. Niranjana S. Mahantshetti has published 13 articles and abstracts on conditions like Asphyxia Neonatorum. You can view a list of Niranjana S. Mahantshetti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mahantshetti's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile